Projects funded by the NCN
Bioconjugates labeled with alpha- and beta-particle emitting radionuclides as potential radiopharmaceuticals in Targeted Radionuclide Therapy.
2019/34/E/ST4/00080
Keywords:
radionuclides chelating ligands prosthetic groups nanobodies internalization HER2 targeted radionuclide therapy
Descriptors:
- ST4_9: Biological chemistry
- ST4_18: Radiation and nuclear chemistry
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
ST4 - Chemistry: physical chemistry/chemical physics, theoretical chemistry, analytical chemistry, inorganic chemistry, organic chemistry, method development
Host institution :
Instytut Chemii i Techniki Jądrowej
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: SONATA BIS 9 - announced on 2019-06-17
Amount awarded: 1 652 200 PLN
Project start date (Y-m-d): 2020-04-06
Project end date (Y-m-d): 2023-04-05
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.